Peptides Codex
Home
Endogenous opioid tetrapeptide

Endomorphin-1

Endomorphin-1 (Tyr-Pro-Trp-Phe-NH2) is an endogenous opioid tetrapeptide and one of the most selective natural agonists of the mu-opioid receptor. First described in 1997, it is widely used as a research tool in opioid pharmacology. This page is educational and makes no claim about pain relief or therapeutic use.

By The Peptides Codex Editorial TeamReviewed July 10, 2026
Length
4 aa
Class
Endogenous opioid tetrapeptide
Function
High-affinity, highly selective agonist of the mu-opioid receptor
Context
Endogenous neuropeptide and research tool in opioid pharmacology; not a Health Canada-authorized product

Among the most selective natural mu-opioid agonists known — proposed as an endogenous ligand of the receptor.

Also known as: EM-1

Part of the Neuropeptides & signaling cluster

Overview

Endomorphin-1 (Tyr-Pro-Trp-Phe-NH2) is an endogenous opioid tetrapeptide and one of the most selective natural agonists of the mu-opioid receptor. First described in 1997, it is widely used as a research tool in opioid pharmacology. This page is educational and makes no claim about pain relief or therapeutic use.

Source & context

Biological / chemical source: Mammalian central nervous system (endogenous)

Primary research or clinical context: Endogenous neuropeptide and research tool in opioid pharmacology; not a Health Canada-authorized product

Structure and selectivity

Endomorphin-1 is a C-terminally amidated tetrapeptide, Tyr-Pro-Trp-Phe-NH2, that binds the mu-opioid receptor with high affinity and unusually high selectivity over delta and kappa receptors. Along with endomorphin-2 it has been proposed as a genuine endogenous ligand of the mu receptor, and it is more prevalent in the brain than in the spinal cord.

Research role and limits

As a selective mu agonist, endomorphin-1 is a common probe in laboratory studies of opioid signalling and analgesia in animal models. Native peptides like this are quickly degraded and do not cross the blood-brain barrier well, which is why they remain research tools rather than medicines. This page is educational and does not describe a treatment.

FAQ about Endomorphin-1

What is Endomorphin-1?+

Endomorphin-1 (Tyr-Pro-Trp-Phe-NH2) is an endogenous opioid tetrapeptide and one of the most selective natural agonists of the mu-opioid receptor. First described in 1997, it is widely used as a research tool in opioid pharmacology. This page is educational and makes no claim about pain relief or therapeutic use.

Is Endomorphin-1 an approved medicine?+

Endomorphin-1 is discussed here as a research / educational topic. Endogenous neuropeptide and research tool in opioid pharmacology; not a Health Canada-authorized product. This is not medical advice.

What is the typical length of Endomorphin-1?+

Endomorphin-1 is commonly described as approximately 4 amino acids (Endogenous opioid tetrapeptide).

Related peptides

References & further reading

  1. 1.Wikipedia — Endomorphin-1
  2. 2.PubMed — Endomorphins and related opioid peptides (review, 12481550)
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Endomorphin-1 educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.